Hypoxia inducible-factor1alpha regulates the metabolic shift of pulmonary hypertensive endothelial cells.

Severe pulmonary hypertension is irreversible and often fatal. Abnormal proliferation and resistance to apoptosis of endothelial cells (ECs) and hypertrophy of smooth muscle cells in this disease are linked to decreased mitochondria and preferential energy generation by glycolysis. We hypothesized this metabolic shift of pulmonary hypertensive ECs is due to greater hypoxia inducible-factor1alpha (HIF-1alpha) expression caused by low levels of nitric oxide combined with low superoxide dismutase activity. We show that cultured ECs from patients with idiopathic pulmonary arterial hypertension (IPAH-ECs) have greater HIF-1alpha expression and transcriptional activity than controls under normoxia or hypoxia, and pulmonary arteries from affected patients have increased expression of HIF-1alpha and its target carbonic anhydrase IX. Decreased expression of manganese superoxide dismutase (MnSOD) in IPAH-ECs paralleled increased HIF-1alpha levels and small interfering (SI) RNA knockdown of MnSOD, but not of the copper-zinc SOD, increased HIF-1 protein expression and hypoxia response element (HRE)-driven luciferase activity in normoxic ECs. MnSOD siRNA also reduced nitric oxide production in supernatants of IPAH-ECs. Conversely, low levels of a nitric oxide donor reduced HIF-1alpha expression in normoxic IPAH-ECs. Finally, mitochondria numbers increased in IPAH-ECs with knockdown of HIF-1alpha. These findings indicate that alterations of nitric oxide and MnSOD contribute to pathological HIF-1alpha expression and account for lower numbers of mitochondria in IPAH-ECs.

[1]  M. Humbert,et al.  Inflammation in pulmonary arterial hypertension , 2003, European Respiratory Journal.

[2]  E. Cesarman,et al.  Antitumorigenesis of antioxidants in a transgenic Rac1 model of Kaposi's sarcoma , 2009, Proceedings of the National Academy of Sciences.

[3]  N. Voelkel,et al.  The cancer paradigm of severe pulmonary arterial hypertension. , 2008, American journal of respiratory and critical care medicine.

[4]  A. Arroliga,et al.  Deficiency of Lung Antioxidants in Idiopathic Pulmonary Arterial Hypertension , 2008, Clinical and translational science.

[5]  L. Oberley,et al.  Manganese superoxide dismutase modulates hypoxia-inducible factor-1 alpha induction via superoxide. , 2008, Cancer research.

[6]  G. Semenza,et al.  Life with Oxygen , 2007, Science.

[7]  S. Erzurum,et al.  Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[8]  Raed A Dweik,et al.  Alterations of cellular bioenergetics in pulmonary artery endothelial cells , 2007, Proceedings of the National Academy of Sciences.

[9]  N. Fukagawa,et al.  Down-regulation of Manganese-Superoxide Dismutase through Phosphorylation of FOXO3a by Akt in Explanted Vascular Smooth Muscle Cells from Old Rats* , 2006, Journal of Biological Chemistry.

[10]  X. Bigard,et al.  Cyclosporin A inhibits hypoxia-induced pulmonary hypertension and right ventricle hypertrophy. , 2006, American journal of respiratory and critical care medicine.

[11]  H. Pelicano,et al.  Glycolysis inhibition for anticancer treatment , 2006, Oncogene.

[12]  S. Archer,et al.  An Abnormal Mitochondrial–Hypoxia Inducible Factor-1&agr;–Kv Channel Pathway Disrupts Oxygen Sensing and Triggers Pulmonary Arterial Hypertension in Fawn Hooded Rats: Similarities to Human Pulmonary Arterial Hypertension , 2006, Circulation.

[13]  S. Black,et al.  Increased oxidative stress in lambs with increased pulmonary blood flow and pulmonary hypertension: role of NADPH oxidase and endothelial NO synthase. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[14]  S. Moncada,et al.  Mitochondria as signaling organelles in the vascular endothelium. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[15]  R. Folz,et al.  Hypoxic pulmonary hypertension: role of superoxide and NADPH oxidase (gp91phox). , 2006, American journal of physiology. Lung cellular and molecular physiology.

[16]  S. Flanagan,et al.  Manganese superoxide dismutase suppresses hypoxic induction of hypoxia-inducible factor-1α and vascular endothelial growth factor , 2005, Oncogene.

[17]  B. Brüne,et al.  NO restores HIF-1α hydroxylation during hypoxia: Role of reactive oxygen species , 2005 .

[18]  E. Jackson,et al.  Estradiol Metabolites Attenuate Monocrotaline-Induced Pulmonary Hypertension in Rats , 2005, Journal of cardiovascular pharmacology.

[19]  W. Seeger,et al.  Imatinib for the treatment of pulmonary arterial hypertension. , 2005, The New England journal of medicine.

[20]  G. Diette,et al.  Decreased exhaled nitric oxide in pulmonary arterial hypertension: response to bosentan therapy. , 2005, American journal of respiratory and critical care medicine.

[21]  S. Hazen,et al.  Superoxide dismutase inactivation in pathophysiology of asthmatic airway remodeling and reactivity. , 2005, The American journal of pathology.

[22]  A. Vinogradov,et al.  Generation of superoxide-radical by the NADH: Ubiquinone oxidoreductase of heart mitochondria , 2005, Biochemistry (Moscow).

[23]  O. Warburg.  über den Stoffwechsel der Carcinomzelle , 1925, Klinische Wochenschrift.

[24]  O. Warburg.  Über den Stoffwechsel der Carcinomzelle , 1924, Naturwissenschaften.

[25]  S. Flanagan,et al.  Manganese superoxide dismutase suppresses hypoxic induction of hypoxia-inducible factor-1alpha and vascular endothelial growth factor. , 2005, Oncogene.

[26]  B. Brüne,et al.  NO restores HIF-1alpha hydroxylation during hypoxia: role of reactive oxygen species. , 2005, Free radical biology & medicine.

[27]  A. Zaiman,et al.  Impaired transforming growth factor-beta signaling in idiopathic pulmonary arterial hypertension. , 2004, American journal of respiratory and critical care medicine.

[28]  S. Hazen,et al.  Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  A. Arroliga,et al.  Nitric oxide and pulmonary arterial pressures in pulmonary hypertension. , 2004, Free radical biology & medicine.

[30]  N. Voelkel,et al.  Oxidative stress in severe pulmonary hypertension. , 2004, American journal of respiratory and critical care medicine.

[31]  W. Bottje,et al.  Investigation of proton conductance in liver mitochondria of broilers with pulmonary hypertension syndrome. , 2004, Poultry science.

[32]  Thilo Hagen,et al.  Redistribution of Intracellular Oxygen in Hypoxia by Nitric Oxide: Effect on HIF1α , 2003, Science.

[33]  S. Wedgwood,et al.  Role of reactive oxygen species in vascular remodeling associated with pulmonary hypertension. , 2003, Antioxidants & redox signaling.

[34]  M. Murphy,et al.  Does interplay between nitric oxide and mitochondria affect hypoxia-inducible transcription factor-1 activity? , 2003, The Biochemical journal.

[35]  S. Moncada,et al.  Regulation of hypoxia-inducible factor-1alpha by nitric oxide through mitochondria-dependent and -independent pathways. , 2003, The Biochemical journal.

[36]  F. Coulet,et al.  Identification of Hypoxia-response Element in the Human Endothelial Nitric-oxide Synthase Gene Promoter* , 2003, Journal of Biological Chemistry.

[37]  G. Semenza.  Targeting HIF-1 for cancer therapy , 2003, Nature Reviews Cancer.

[38]  K. Brown,et al.  Expression of human herpesvirus 8 in primary pulmonary hypertension. , 2003, The New England journal of medicine.

[39]  B. Brüne,et al.  Nitric oxide impairs normoxic degradation of HIF-1alpha by inhibition of prolyl hydroxylases. , 2003, Molecular biology of the cell.

[40]  P. Carmeliet,et al.  Heterozygous deficiency of hypoxia-inducible factor-2alpha protects mice against pulmonary hypertension and right ventricular dysfunction during prolonged hypoxia. , 2003, The Journal of clinical investigation.

[41]  N. Chandel,et al.  Hypoxic but not anoxic stabilization of HIF-1alpha requires mitochondrial reactive oxygen species. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[42]  W. Bottje,et al.  Heart and breast muscle mitochondrial dysfunction in pulmonary hypertension syndrome in broilers (Gallus domesticus). , 2002, Comparative biochemistry and physiology. Part A, Molecular & integrative physiology.

[43]  Till Acker,et al.  Loss of HIF-2α and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice , 2002, Nature Medicine.

[44]  C. Thompson,et al.  Phosphatidylinositol 3-Kinase/Akt Signaling Is Neither Required for Hypoxic Stabilization of HIF-1α nor Sufficient for HIF-1-dependent Target Gene Transcription* , 2002, The Journal of Biological Chemistry.

[45]  J. Dyck,et al.  Dichloroacetate, a Metabolic Modulator, Prevents and Reverses Chronic Hypoxic Pulmonary Hypertension in Rats: Role of Increased Expression and Activity of Voltage-Gated Potassium Channels , 2002, Circulation.

[46]  P. Carmeliet,et al.  Loss of HIF-2α and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice , 2002, Nature Medicine.

[47]  R. Speich,et al.  Clinical classification of pulmonary hypertension. , 2004, Journal of the American College of Cardiology.

[48]  G. Semenza,et al.  Expression of angiogenesis‐related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis , 2001, The Journal of pathology.

[49]  J. Cracowski,et al.  Increased lipid peroxidation in patients with pulmonary hypertension. , 2001, American journal of respiratory and critical care medicine.

[50]  N. Voelkel,et al.  Microsatellite Instability of Endothelial Cell Growth and Apoptosis Genes Within Plexiform Lesions in Primary Pulmonary Hypertension , 2001, Circulation research.

[51]  A. Arroliga,et al.  High Levels of Nitric Oxide in Individuals with Pulmonary Hypertension Receiving Epoprostenol Therapy , 2001, Lung.

[52]  P H Watson,et al.  Hypoxia-inducible expression of tumor-associated carbonic anhydrases. , 2000, Cancer research.

[53]  R. Johns,et al.  Normoxic stabilization of hypoxia-inducible factor-1 expression and activity: redox-dependent effect of nitrogen oxides. , 2000, Molecular pharmacology.

[54]  F. Agani,et al.  The Role of Mitochondria in the Regulation of Hypoxia-inducible Factor 1 Expression during Hypoxia* , 2000, The Journal of Biological Chemistry.

[55]  S. Hodge,et al.  Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. , 2000, American journal of human genetics.

[56]  R. Trembath,et al.  Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension , 2000, Nature Genetics.

[57]  M. Makuuchi,et al.  Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide. , 2000, Blood.

[58]  T. Beaty,et al.  Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1alpha. , 1999, The Journal of clinical investigation.

[59]  N. Chandel,et al.  Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[60]  A. Arroliga,et al.  Biochemical reaction products of nitric oxide as quantitative markers of primary pulmonary hypertension. , 1998, American journal of respiratory and critical care medicine.

[61]  N. Voelkel,et al.  Primary pulmonary hypertension between inflammation and cancer. , 1998, Chest.

[62]  G. Semenza,et al.  Carbon Monoxide and Nitric Oxide Suppress the Hypoxic Induction of Vascular Endothelial Growth Factor Gene via the 5′ Enhancer* , 1998, The Journal of Biological Chemistry.

[63]  K. Shroyer,et al.  Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. , 1998, The Journal of clinical investigation.

[64]  J. Herman,et al.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[65]  N. Voelkel,et al.  Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. , 1995, The Journal of clinical investigation.

[66]  B. Groves,et al.  Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. , 1994, The American journal of pathology.